The first drug to increase women’s sexual desire was fibanserin, produced under the Addyi brand and already approved by the American Food and Drug Administration (FDA). “Eddy” was developed as an antidepressant. It is a non-hormonal treatment for hypoactive sexual desire disorder in premenopausal women. This disorder is not related to physical or mental health or relationship problems.

It is important to understand that this tool does not yet have an alternative (and it itself has not yet got out of the United States). So if you are offered something like that, it will be some useless herbs.

Women’s Viagra should not be compared with men’s. The active ingredient is sildenafil, which relaxes the muscles and dilates the blood vessels of the penis to increase blood flow and induce an erection. Women, on the other hand, lack arousal, so the drug helps to balance brain chemistry and elicit a “sexual response,” as well as increase sensitivity to stimulation. That is, it works in a completely different way.

The study did not reveal any health hazards. The list of side effects is quite standard: insomnia, nausea, dry mouth, fatigue, low blood pressure.

Since all people are different, as well as the causes of lack of sexual desire, the remedy cannot be suitable for everyone. But in the process of research, a positive effect was obtained, so this remedy can be a solution to the problem. The drug went through three phases of clinical trials for 24 weeks and proved its usefulness. About 10% of women noted an improvement (as well as a significant improvement) in sexual desire from the eighth to the 24th week. It’s more than zero anyway!